Joseph Ross Journalist Profile

Articles

Privately Negotiated Facility Fees at Ambulatory Surgery Centers and Hospitals

Nov 5, 2024 | ajmc.com | Daphne T. Hao |Vinay K. Rathi |Joseph Ross |Roy Xiao

PublicationArticleNovember 5, 2024The American Journal of Managed CareNovember 2024Author(s):,Private negotiated facility fees at hospitals are on average double the ambulatory surgery center facility fees for common outpatient procedures. Am J Manag Care. 2024;30(11):In Press_____Takeaway PointsOn average, hospital facility fees are more than double the ambulatory surgery center (ASC) facility fees for common outpatient procedures.
What’s Missing From Japan’s Defense Buildup?

Apr 5, 2024 | thediplomat.com | Joseph Ross

In 1956, while commenting on Japan’s ability to defend itself from attack, Japanese Prime Minister Ichiro Hatoyama said that the government should not “merely sit and wait to die.” China’s growing conventional strike and amphibious assault forces are pushing Japan’s Ministry of Defense to reshape the Japan Self-Defense Forces (JSDF).
What’s Missing From Japan’s Defense Buildup? - Tribune Content Agency

Apr 4, 2024 | tribunecontentagency.com | Joseph Ross

China’s growing conventional strike and amphibious assault forces are pushing Japan’s Ministry of Defense to reshape the Japan Self-Defense Forces (JSDF). Long-range strike munitions and launchers are now the centerpiece of a defense buildup to deter an attack on Japan and to rapidly destroy the enemy if deterrence fails. The problem is that the intelligence, surveillance, and reconnaissance (ISR) architecture to strike targets at farther distances is missing from Japan’s buildup.
Reforming The Medical Device Recall Process—A Call For Accountability | Health Affairs Forefront

Feb 15, 2024 | healthaffairs.org | Kushal Kadakia |Vinay K. Rathi |Sanket S Dhruva |Maryam Mooghali |Claudia See |Joseph Ross | +1 more

The Food and Drug Administration (FDA) issues recalls for thousands of medical devices yearly due to safety issues. In January 2024, the Government Accountability Office (GAO) formally accepted a request from Congress, initiated by Senators Durbin (D-IL) and Blumenthal (D-CT), to review FDA’s oversight of device recalls in the wake of the far-reaching and ongoing recall initiated by Philips Respironics, which affected 15 million devices.
The Philips CPAP nightmare exposes shortcomings in medical device regulation

Feb 6, 2024 | statnews.com | Kushal Kadakia |Joseph Ross |Vinay K. Rathi

Millions of Americans’ bedtime routine includes wearing a mask attached to a respiratory machine that pushes air into their lungs, supporting their breathing during sleep. These airway pressure machines, known as CPAP or BiPAP depending on their design, are sophisticated medical devices that have been used for decades by patients with sleep disorders like obstructive sleep apnea.
An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized clinical trials - npj Digital Medicine

Nov 24, 2023 | nature.com | Deepak L. Bhatt |Joseph Ross |Harlan M. Krumholz

AbstractRandomized clinical trials (RCT) represent the cornerstone of evidence-based medicine but are resource-intensive. We propose and evaluate a machine learning (ML) strategy of adaptive predictive enrichment through computational trial phenomaps to optimize RCT enrollment.
Challenges and solutions to advancing heath equity with medical devices - Nature Biotechnology

Apr 10, 2023 | nature.com | Vinay K. Rathi |Joseph Ross

In October 2022, the US Food and Drug Administration (FDA) proposed updating its Breakthrough Devices Program (BDP) to reduce disparities in health and health care1. Created by Congress in 2016, the BDP is intended to expedite developing and authorizing devices that diagnose or treat life-threatening conditions and represent technologies that either lack approved alternatives or offer substantial advantages when compared to existing modalities2.
FDA Class I Recalls for Moderate, High-Risk Medical Devices

Mar 16, 2023 | dovepress.com | Maryam Mooghali |Joseph Ross |Kushal Kadakia |Sanket S Dhruva

IntroductionThe Food and Drug Administration (FDA) is responsible for monitoring the safety and effectiveness of medical devices in the United States.